29.12.2012 - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb and Pfizer, for treatment in patients with atrial fibrillation, or irregular...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)